Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standalone versus combined preserflo MicroShunt surgery: A two-year controlled cohort study.

Eye (London, England)·2026
Same author

Ophthalmologic assessment and intracranial pressure in children: diagnostic methods, clinical correlations, and future directions.

Frontiers in pediatrics·2026
Same author

Three-year clinical outcomes of PRESERFLO MicroShunt implantation in eyes with previous failed trabeculectomy.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026
Same author

Efficacy of Manuka honey eye drops in managing dry eye disease after cataract surgery: a prospective controlled study.

Frontiers in ophthalmology·2026
Same author

Is the interventional glaucoma paradigm reflected in real-world practice? Insights from iStent combined with cataract surgery (2010-2022).

European journal of ophthalmology·2026
Same author

Optimizing topical glaucoma treatment outcomes: When less is better. A review on the clinical benefits of reducing treatment burden in glaucoma management.

European journal of ophthalmology·2026

Related Experiment Video

Updated: May 20, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

Recent patents and developments in glaucoma biomarkers.

Basilio Colligris1, Almudena Crooke, Xavier Gasull

  • 1Departamento de Bioquímica y Biología Molecular IV, E.U. Óptica, Universidad Complutense de Madrid, Madrid, Spain.

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
|July 26, 2012
PubMed
Summary

Early glaucoma diagnosis is crucial to prevent vision loss. This review explores molecular genetics patents and literature for improved diagnostic methods, aiming for earlier detection and better disease management.

More Related Videos

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

Related Experiment Videos

Last Updated: May 20, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

Area of Science:

  • Ophthalmology
  • Genetics
  • Medical Diagnostics

Background:

  • Glaucoma, often linked to elevated intraocular pressure, can lead to irreversible optic nerve damage and blindness.
  • The disease is frequently inherited and asymptomatic in early stages, making timely diagnosis challenging.
  • Current diagnostic methods rely on detecting established optic nerve damage and visual field loss, often after significant cell degeneration.

Purpose of the Study:

  • To review recent patents and literature on glaucoma diagnosis.
  • To highlight the potential of molecular genetics in improving early glaucoma detection.
  • To discuss advancements in understanding glaucoma's molecular mechanisms for better management.

Main Methods:

  • Systematic review of patents related to glaucoma diagnostics.
  • Literature search focusing on molecular genetics in glaucoma.
  • Analysis of current and emerging diagnostic approaches.

Main Results:

  • Genetic studies have identified numerous genes and chromosomal loci associated with glaucoma.
  • Molecular genetics offers promising avenues for early glaucoma detection, surpassing traditional methods.
  • Patents reveal ongoing innovation in genetic and molecular diagnostic tools for glaucoma.

Conclusions:

  • Early diagnosis of glaucoma is critical to prevent vision loss and blindness.
  • Molecular genetics represents a significant advancement for early and accurate glaucoma diagnosis.
  • Further research into glaucoma's genetic underpinnings is essential for developing effective early detection and treatment strategies.